Insmed
INSM
INSM
222 hedge funds and large institutions have $3.09B invested in Insmed in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 79 increasing their positions, 77 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
222
Holders Change
-7
Holders Change %
-3.06%
% of All Funds
3.5%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
25
Increased
79
Reduced
77
Closed
32
Calls
$9.69M
Puts
$18.6M
Net Calls
-$8.87M
Net Calls Change
-$11.4M
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$21.1M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$21M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$12.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$9.42M |
Top Sellers
| 1 |
Barclays
London,
United Kingdom
|
-$15.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$13.3M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$7.72M |
| 4 |
Morgan Stanley
New York
|
-$7.64M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.43M |
